BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34395759)

  • 1. Long-term
    Yarlett N; Morada M
    Bio Protoc; 2018 Aug; 8(15):e2947. PubMed ID: 34395759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous culture of Cryptosporidium parvum using hollow fiber technology.
    Morada M; Lee S; Gunther-Cummins L; Weiss LM; Widmer G; Tzipori S; Yarlett N
    Int J Parasitol; 2016 Jan; 46(1):21-9. PubMed ID: 26341006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Culture of Cryptosporidium parvum Using Hollow Fiber Bioreactor: Applications for Simultaneous Pharmacokinetic and Pharmacodynamic Evaluation of Test Compounds.
    Yarlett N; Morada M; Gobin M; Van Voorhis W; Arnold S
    Methods Mol Biol; 2020; 2052():335-350. PubMed ID: 31452171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and virulence analysis of in vitro cultured Cryptosporidium parvum.
    Yarlett N; Morada M; Schaefer DA; Ackman K; Carranza E; Baptista RP; Riggs MW; Kissinger JC
    PLoS Pathog; 2024 Feb; 20(2):e1011992. PubMed ID: 38416794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical comparison of excystation methods in Cryptosporidium parvum oocysts.
    Pecková R; Stuart PD; Sak B; Květoňová D; Kváč M; Foitová I
    Vet Parasitol; 2016 Oct; 230():1-5. PubMed ID: 27884435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to propagate Cryptosporidium spp. in cell-free culture.
    Girouard D; Gallant J; Akiyoshi DE; Nunnari J; Tzipori S
    J Parasitol; 2006 Apr; 92(2):399-400. PubMed ID: 16729703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectivity of Cryptosporidium parvum oocysts following cryopreservation.
    Kim HC; Healey MC
    J Parasitol; 2001 Oct; 87(5):1191-4. PubMed ID: 11695396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Culture of Cryptosporidium parvum Using Stem Cell-Derived Intestinal Epithelial Monolayers.
    Wilke G; Wang Y; Ravindran S; Stappenbeck T; Witola WH; Sibley LD
    Methods Mol Biol; 2020; 2052():351-372. PubMed ID: 31452172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal-mouse infectivity of intact Cryptosporidium parvum oocysts isolated after optimized in vitro excystation.
    Hou L; Li X; Dunbar L; Moeller R; Palermo B; Atwill ER
    Appl Environ Microbiol; 2004 Jan; 70(1):642-6. PubMed ID: 14711704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and potential use of a Cryptosporidium parvum virus (CPV) antigen for detecting C. parvum oocysts.
    Kniel KE; Higgins JA; Trout JM; Fayer R; Jenkins MC
    J Microbiol Methods; 2004 Aug; 58(2):189-95. PubMed ID: 15234516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of the relationship between use of in vitro cell culture-quantitative PCR and a mouse-based bioassay for evaluating critical factors affecting the disinfection performance of pulsed UV light for treating Cryptosporidium parvum oocysts in saline.
    Garvey M; Farrell H; Cormican M; Rowan N
    J Microbiol Methods; 2010 Mar; 80(3):267-73. PubMed ID: 20096310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of viability and infectivity of Cryptosporidium parvum oocysts stored in potassium dichromate solution and chlorinated tap water.
    Chen F; Huang K; Qin S; Zhao Y; Pan C
    Vet Parasitol; 2007 Nov; 150(1-2):13-7. PubMed ID: 17954011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence of geographically different Cryptosporidium parvum isolates in experimental animal model.
    Sayed FG; Hamza AI; Galal LA; Sayed DM; Gaber M
    Ann Parasitol; 2016 Oct; 62(3):221-32. PubMed ID: 27770762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection.
    Di Giovanni GD; LeChevallier MW
    Appl Environ Microbiol; 2005 Mar; 71(3):1495-500. PubMed ID: 15746352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts.
    Korich DG; Marshall MM; Smith HV; O'Grady J; Bukhari Z; Fricker CR; Rosen JP; Clancy JL
    J Eukaryot Microbiol; 2000; 47(3):294-8. PubMed ID: 10847347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viability and infectivity of Cryptosporidium parvum oocysts are retained upon intestinal passage through a refractory avian host.
    Graczyk TK; Cranfield MR; Fayer R; Anderson MS
    Appl Environ Microbiol; 1996 Sep; 62(9):3234-7. PubMed ID: 8795213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture.
    Hijjawi NS; Meloni BP; Morgan UM; Thompson RC
    Int J Parasitol; 2001 Aug; 31(10):1048-55. PubMed ID: 11429168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability and infectivity of Cryptosporidium parvum oocysts detected in river water in Hokkaido, Japan.
    Tsushima Y; Karanis P; Kamada T; Xuan X; Makala LH; Tohya Y; Akashi H; Nagasawa H
    J Vet Med Sci; 2003 May; 65(5):585-9. PubMed ID: 12808210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts.
    Quilez J; Sanchez-Acedo C; Avendaño C; del Cacho E; Lopez-Bernad F
    Appl Environ Microbiol; 2005 May; 71(5):2479-83. PubMed ID: 15870337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.